Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)

por Shibasaki, Chiyo, Itagaki, Kei, Abe, Hiromi, Kajitani, Naoto, Okada-Tsuchioka, Mami, Takebayashi, Minoru
Publicado 2017

Decreased serum levels of thrombospondin‐1 in female depressed patients

por Okada‐Tsuchioka, Mami, Omori, Wataru, Kajitani, Naoto, Shibasaki, Chiyo, Itagaki, Kei, Takebayashi, Minoru
Publicado 2019

Antidepressant amitriptyline‐induced matrix metalloproteinase‐9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line‐derived neurotrophic factor mRN...

por Abe, Hiromi, Kajitani, Naoto, Okada‐Tsuchioka, Mami, Omori, Wataru, Yatsumoto, Masahide, Takebayashi, Minoru
Publicado 2019

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

por Shibasaki, Chiyo, Takebayashi, Minoru, Itagaki, Kei, Abe, Hiromi, Kajitani, Naoto, Okada-Tsuchioka, Mami, Yamawaki, Shigeto
Publicado 2016

PS159. Altered serum levels of matrix metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders.

por Shibasaki, Chiyo, Takebayashi, Minoru, Itagaki, Kei, Abe, Hiromi, Kajitani, Naoto, Okada-Tsuchioka, Mami, Yamawaki, Shigeto
Publicado 2016

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders

por Omori, Wataru, Itagaki, Kei, Kajitani, Naoto, Abe, Hiromi, Okada‐Tsuchioka, Mami, Okamoto, Yasumasa, Takebayashi, Minoru
Publicado 2019

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia

por Omori, Wataru, Hattori, Kotaro, Kajitani, Naoto, Okada-Tsuchioka, Mami, Boku, Shuken, Kunugi, Hiroshi, Okamoto, Yasumasa, Takebayashi, Minoru
Publicado 2020

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive thera...

por Abe, Hiromi, Okada‐Tsuchioka, Mami, Kajitani, Naoto, Omori, Wataru, Itagaki, Kei, Shibasaki, Chiyo, Boku, Shuken, Matsuhisa, Tetsuaki, Takebayashi, Minoru
Publicado 2023

PS158. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression

por Itagake, Kei, Abe, Hiromi, Fujita, Yousuke, Kajitani, Naoato, Oga, Kenichi, Okada-Tsuchioka, Mami, Omori, Wataru, Shibasaki, Chiyo, Takebayashi, Minoru
Publicado 2016

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia

por Omori, Wataru, Kano, Kuniyuki, Hattori, Kotaro, Kajitani, Naoto, Okada-Tsuchioka, Mami, Boku, Shuken, Kunugi, Hiroshi, Aoki, Junken, Takebayashi, Minoru
Publicado 2021

Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline

por Kajitani, Naoto, Hisaoka-Nakashima, Kazue, Morioka, Norimitsu, Okada-Tsuchioka, Mami, Kaneko, Masahiro, Kasai, Miho, Shibasaki, Chiyo, Nakata, Yoshihiro, Takebayashi, Minoru
Publicado 2012

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder

por Itagaki, Kei, Takebayashi, Minoru, Abe, Hiromi, Shibasaki, Chiyo, Kajitani, Naoto, Okada-Tsuchioka, Mami, Hattori, Kotaro, Yoshida, Sumiko, Kunugi, Hiroshi, Yamawaki, Shigeto
Publicado 2019

Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study

por Shimizu, Hideyuki, Takebayashi, Minoru, Tani, Masayuki, Tanaka, Hiroaki, Yamagata, Bun, Kurosawa, Kenzo, Yamada, Hiroki, Hachisu, Mitsugu, Hisaoka-Nakashima, Kazue, Okada-Tsuchioka, Mami, Mimura, Masaru, Iwanami, Akira
Publicado 2013